[go: up one dir, main page]

CU20190091A7 - FORMULACIONES QUE COMPRENDEN UN EXTRACTO DE FLAVONOIDES OBTENIDO DE LA ESPECIE TALIPARITI ELATUM Sw. - Google Patents

FORMULACIONES QUE COMPRENDEN UN EXTRACTO DE FLAVONOIDES OBTENIDO DE LA ESPECIE TALIPARITI ELATUM Sw.

Info

Publication number
CU20190091A7
CU20190091A7 CU2019000091A CU20190091A CU20190091A7 CU 20190091 A7 CU20190091 A7 CU 20190091A7 CU 2019000091 A CU2019000091 A CU 2019000091A CU 20190091 A CU20190091 A CU 20190091A CU 20190091 A7 CU20190091 A7 CU 20190091A7
Authority
CU
Cuba
Prior art keywords
talipariti
elatum
extract obtained
flavonoid extract
formulations including
Prior art date
Application number
CU2019000091A
Other languages
English (en)
Inventor
Sarmiento Maydel Barrios
Fonseca Luis Arturo Fonseca
Blanco Loraine Licet Infante
Peguero Yanay Montano
Figueredo Yanier Núñez
Yaquis Alejandro Saúl Padrón
Sánchez Jeney Ramírez
Días Jacqueline Aylema Romero
Guerra Maylin Wong
Original Assignee
Centro De Investig Y Desarrollo De Medicamentos Cidem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Investig Y Desarrollo De Medicamentos Cidem filed Critical Centro De Investig Y Desarrollo De Medicamentos Cidem
Priority to CU2019000091A priority Critical patent/CU20190091A7/es
Priority to US17/768,532 priority patent/US20240123008A1/en
Priority to MX2022005877A priority patent/MX2022005877A/es
Priority to PCT/CU2020/050005 priority patent/WO2021121443A2/es
Priority to BR112022009475A priority patent/BR112022009475A2/pt
Priority to CA3161432A priority patent/CA3161432A1/en
Publication of CU20190091A7 publication Critical patent/CU20190091A7/es
Priority to ECSENADI202246581A priority patent/ECSP22046581A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A61K36/5775—Hibiscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<p>Esta invención se relaciona con el campo de la salud y en especial con el tratamiento de trastornos de memoria. La invención consiste en la elaboración de formulaciones farmacéuticas orales a partir de un extracto de flavonoides obtenido de la especie <em>Talipariti elatum Sw</em>. que actúa mejorando los diferentes tipos de memoria, tanto a corto como largo plazo asociado con diferentes patologías y con el envejecimiento poblacional en humanos.</p>
CU2019000091A 2019-11-14 2019-11-14 FORMULACIONES QUE COMPRENDEN UN EXTRACTO DE FLAVONOIDES OBTENIDO DE LA ESPECIE TALIPARITI ELATUM Sw. CU20190091A7 (es)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CU2019000091A CU20190091A7 (es) 2019-11-14 2019-11-14 FORMULACIONES QUE COMPRENDEN UN EXTRACTO DE FLAVONOIDES OBTENIDO DE LA ESPECIE TALIPARITI ELATUM Sw.
US17/768,532 US20240123008A1 (en) 2019-11-14 2020-11-13 Use of a flavanoid extract obtained from the species talipariti elatum sw, formulations comprising same and treatment method
MX2022005877A MX2022005877A (es) 2019-11-14 2020-11-13 Uso de un extracto de flavonoides obtenido de la especie talipariti elatum sw., formulaciones que lo comprenden y metodo de tratamiento.
PCT/CU2020/050005 WO2021121443A2 (es) 2019-11-14 2020-11-13 USO DE UN EXTRACTO DE FLAVONOIDES OBTENIDO DE LA ESPECIE TALIPARITI ELATUM Sw., FORMULACIONES QUE LO COMPRENDEN Y MÉTODO DE TRATAMIENTO
BR112022009475A BR112022009475A2 (pt) 2019-11-14 2020-11-13 Uso de um extrato de flavonoide obtido a partir de espécies talipariti elatum sw., suas formulações e métodos de tratamento
CA3161432A CA3161432A1 (en) 2019-11-14 2020-11-13 Use of a flavonoid extract obtained from the species talipariti elatum sw., its formulations and treatment methods
ECSENADI202246581A ECSP22046581A (es) 2019-11-14 2022-06-09 Uso de un extracto de flavonoides obtenido de la especie talipariti elatum sw., formulaciones que lo comprenden y m?todo de tratamiento

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU2019000091A CU20190091A7 (es) 2019-11-14 2019-11-14 FORMULACIONES QUE COMPRENDEN UN EXTRACTO DE FLAVONOIDES OBTENIDO DE LA ESPECIE TALIPARITI ELATUM Sw.

Publications (1)

Publication Number Publication Date
CU20190091A7 true CU20190091A7 (es) 2021-06-08

Family

ID=76328721

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2019000091A CU20190091A7 (es) 2019-11-14 2019-11-14 FORMULACIONES QUE COMPRENDEN UN EXTRACTO DE FLAVONOIDES OBTENIDO DE LA ESPECIE TALIPARITI ELATUM Sw.

Country Status (7)

Country Link
US (1) US20240123008A1 (es)
BR (1) BR112022009475A2 (es)
CA (1) CA3161432A1 (es)
CU (1) CU20190091A7 (es)
EC (1) ECSP22046581A (es)
MX (1) MX2022005877A (es)
WO (1) WO2021121443A2 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101360109B1 (ko) * 2011-11-30 2014-02-12 대한민국 (식품의약품안전처장) 스피노신을 포함하는 인지기능 장애 질환 예방 또는 치료용 약학조성물
EP3703724A1 (en) * 2017-11-02 2020-09-09 NatureCeuticals Sdn. Bhd. Extract of orthosiphon stamineus, formulations, and uses thereof

Also Published As

Publication number Publication date
WO2021121443A3 (es) 2022-01-06
US20240123008A1 (en) 2024-04-18
WO2021121443A2 (es) 2021-06-24
ECSP22046581A (es) 2022-08-31
BR112022009475A2 (pt) 2022-07-26
CA3161432A1 (en) 2021-06-24
MX2022005877A (es) 2022-06-14

Similar Documents

Publication Publication Date Title
EP3445356A4 (en) FAST PLANT-BASED MEDICAL CONNECTIONS AND FOOD SUPPLEMENTS
MX2017008698A (es) Composiciones multi-suplementos.
GT200600297A (es) Nuevos anticuerpos anti-madcam
CO2018013029A2 (es) Uso de indazoles sustituidos para el tratamiento y la prevención de enfermedades en animales
MX2015009991A (es) Composiciones y metodos.
MX387464B (es) Combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos.
MA55027A (fr) Formulations plaisante au goût
AR106644A1 (es) Composiciones nutricionales sinergísticas y usos de las mismas
MX2021012894A (es) Compuestos ciclicos de fosfato.
EP4167937A4 (en) PROBIOTIC SKIN FORMULATIONS
PH12019502241A1 (en) Berberine alkaloids in the prevention and/or treatments of intestinal disease
GT200500378A (es) Macrolidos
CU20210077A7 (es) Extractos bacterianos estables como fármacos
MX2016016865A (es) Reduccion de infecciones en instalaciones de atencion medica usando composiciones fotocataliticas.
EP3861866A4 (en) COMPOSITION WITH MOLOKHIA EXTRACT AS AN INGREDIENT TO IMPROVE GUEST MICROBIOME OR RELIEVE, PREVENT OR TREAT INTESTINAL INFLAMMATION, LEAKY GUT SYNDROME, OBESITY OR METABOLIC DISEASE
CU20190091A7 (es) FORMULACIONES QUE COMPRENDEN UN EXTRACTO DE FLAVONOIDES OBTENIDO DE LA ESPECIE TALIPARITI ELATUM Sw.
BR112012017540A2 (pt) formulações antiparasitárias tópicas
DK2285391T3 (da) Bukkehornsekstrakt til behandling af humane og animalske sygdomme, som involverer flagellatparasitter
ITMI20051231A1 (it) Formulazioni farmaceutiche contenenti colostro e calcio folinato per il trattamento delle affezioni del cavo orale
IL304358A (en) Formulations of breast milk for external use
GB2550750A (en) Anthelmintic compounds
ES1240969Y (es) Composiciones de cereales que contienen oligosacaridos de la leche humana
EP4216945A4 (en) Formulations comprising botanical extracts
EP4199725A4 (en) DISINFECTANT FORMULATIONS
CR20220587A (es) Formulaciones farmacéuticas